ImmunityBio,

+$0.20 (+2.18%) As of 3:28 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ImmunityBio, and other ETFs, options, and stocks.

About IBRX

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases.

CEO
Richard Adcock
Employees
171
Headquarters
Culver City, California
Founded
2014

IBRX Key Statistics

Market Cap
3.57B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
972.18K
High Today
$9.19
Low Today
$8.75
Open Price
$9.01
Volume
569.34K
52 Week High
$45.42
52 Week Low
$6.80

IBRX Earnings

-$0.23
-$0.15
-$0.08
$0.00
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Nov 9, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure